Clinical Research Directory

Pharmacokinetics (PK) and Tolerability of AVP-786 in Healthy Volunteers

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.

Summary

To assess the single- and multiple-dose pharmacokinetic (PK), safety and tolerability of AVP-786 in healthy volunteers.

Official title: A Phase 1, Single-center, Randomized, Double-blind, Study to Assess the Pharmacokinetics, Safety and Tolerability of Single and Multiple Doses of AVP-786 (Deuterated Dextromethorphan) in Healthy Volunteers

Key Details

Conditions

Interventions

Locations (1)